Nurix Therapeutics Stock (NASDAQ: NRIX) stock price, news, charts, stock research, profile.
Open | $14.050 |
Close | $13.750 |
Volume / Avg. | 519.873K / 987.774K |
Day Range | 13.520 - 14.420 |
52 Wk Range | 4.220 - 18.120 |
Market Cap | $827.464M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 12.39% |
Days to Cover | 8.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nurix Therapeutics (NASDAQ: NRIX) through any online brokerage.
Other companies in Nurix Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB) and Zentalis Pharma (NASDAQ:ZNTL).
The latest price target for Nurix Therapeutics (NASDAQ: NRIX) was reported by RBC Capital on Thursday, April 11, 2024. The analyst firm set a price target for 23.00 expecting NRIX to rise to within 12 months (a possible 69.74% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $13.55 last updated Today at April 24, 2024 at 6:29 PM EDT.
There are no upcoming dividends for Nurix Therapeutics.
Nurix Therapeutics’s Q2 earnings are confirmed for Thursday, July 11, 2024.
There is no upcoming split for Nurix Therapeutics.
Nurix Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.